Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Gurioli C, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Esposito M, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence study group. Stingeni L, et al. Among authors: ortoncelli m. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18. J Eur Acad Dermatol Venereol. 2023. PMID: 36225088 No abstract available.
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Solitano V, Facheris P, Petersen M, D'Amico F, Ortoncelli M, Aletaha D, Olivera PA, Bieber T, Ramiro S, Ghosh S, D'Agostino MA, Siegmund B, Chary-Valckenaere I, Hart A, Dagna L, Magro F, Felten R, Kotze PG, Jairath V, Costanzo A, Kristensen LE, Biroulet LP, Danese S. Solitano V, et al. Among authors: ortoncelli m. Autoimmun Rev. 2024 Mar;23(3):103504. doi: 10.1016/j.autrev.2023.103504. Epub 2023 Dec 20. Autoimmun Rev. 2024. PMID: 38128748
Adult-onset cutaneous mastocytosis in monozygotic twins.
Quaglino P, Mola F, Peroni A, Ortoncelli M, Di Bello C, Savoia P, Bernengo MG. Quaglino P, et al. Among authors: ortoncelli m. J Am Acad Dermatol. 2011 Sep;65(3):680-681. doi: 10.1016/j.jaad.2010.07.018. J Am Acad Dermatol. 2011. PMID: 21839339 Free article. No abstract available.
Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT, Viola R, Fierro MT, Ribero S, Ortoncelli M. Giura MT, et al. Among authors: ortoncelli m. Dermatol Ther. 2020 Jan;33(1):e13201. doi: 10.1111/dth.13201. Epub 2019 Dec 28. Dermatol Ther. 2020. PMID: 31856368
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: ortoncelli m. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
111 results